Hartung DM - Search Results

1

Medicare Part D Coverage Restrictions and Patient Cost-Sharing for Opioids Commonly Used for Cancer Pain, 2015-2021.

Bao Y, Zhang H, Hartung DM, Witkin LR, Paice JA. Bao Y, et al. Among authors: hartung dm. JCO Oncol Pract. 2022 Oct;18(10):e1574-e1586. doi: 10.1200/OP.21.00867. Epub 2022 Jul 7. JCO Oncol Pract. 2022. PMID: 35797497 Free PMC article.

2

Trends In Coverage For Disease-Modifying Therapies For Multiple Sclerosis In Medicare Part D.

Hartung DM, Johnston KA, Irwin A, Markwardt S, Bourdette DN. Hartung DM, et al. Health Aff (Millwood). 2019 Feb;38(2):303-312. doi: 10.1377/hlthaff.2018.05357. Health Aff (Millwood). 2019. PMID: 30715973

3

Rates of adverse events of long-acting opioids in a state Medicaid program.

Hartung DM, Middleton L, Haxby DG, Koder M, Ketchum KL, Chou R. Hartung DM, et al. Ann Pharmacother. 2007 Jun;41(6):921-8. doi: 10.1345/aph.1K066. Epub 2007 May 15. Ann Pharmacother. 2007. PMID: 17504834

4

A chronic opioid therapy dose reduction policy in primary care.

Weimer MB, Hartung DM, Ahmed S, Nicolaidis C. Weimer MB, et al. Among authors: hartung dm. Subst Abus. 2016;37(1):141-7. doi: 10.1080/08897077.2015.1129526. Subst Abus. 2016. PMID: 26685018

5

Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes.

Hartung DM, Kim H, Ahmed SM, Middleton L, Keast S, Deyo RA, Zhang K, McConnell KJ. Hartung DM, et al. Subst Abus. 2018;39(2):239-246. doi: 10.1080/08897077.2017.1389798. Epub 2018 May 16. Subst Abus. 2018. PMID: 29016245 Free PMC article.

6

Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018.

Hartung DM, Johnston K, Geddes J, Leichtling G, Priest KC, Korthuis PT. Hartung DM, et al. JAMA. 2019 Feb 12;321(6):607-609. doi: 10.1001/jama.2018.20391. JAMA. 2019. PMID: 30747957 Free PMC article.

7

Opioid prescribing on discharge to skilled nursing facilities.

Hubsky AR, Noble BN, Hartung DM, Tjia J, Lapane KL, Furuno JP. Hubsky AR, et al. Among authors: hartung dm. Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1183-1188. doi: 10.1002/pds.5075. Epub 2020 Jul 29. Pharmacoepidemiol Drug Saf. 2020. PMID: 32725962

8

Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy.

Hallvik SE, Johnston K, Geddes J, Leichtling G, Korthuis PT, Hartung DM. Hallvik SE, et al. Among authors: hartung dm. Pharmacoepidemiol Drug Saf. 2021 Mar;30(3):395-399. doi: 10.1002/pds.5096. Epub 2020 Aug 26. Pharmacoepidemiol Drug Saf. 2021. PMID: 32844498 Free PMC article.

9

Exploring Patient Perceptions of Opioid Treatment Agreements in a Community Health Center Environment.

Irwin AN, Braden-Suchy N, Hartung DM. Irwin AN, et al. Among authors: hartung dm. Pain Med. 2021 Apr 20;22(4):970-978. doi: 10.1093/pm/pnaa344. Pain Med. 2021. PMID: 33040144

10

Decreasing Trends in Opioid Prescribing on Discharge to Hospice Care.

Furuno JP, Noble BN, Fromme EK, Hartung DM, Tjia J, Lynn M, Teno JM. Furuno JP, et al. Among authors: hartung dm. J Pain Symptom Manage. 2021 Nov;62(5):1026-1033. doi: 10.1016/j.jpainsymman.2021.03.025. Epub 2021 Apr 10. J Pain Symptom Manage. 2021. PMID: 33848567 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters